Myda Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Myda Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $544,392 - $661,576	800 Added 66.67%	2,000 $1.64 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $564,712 - $613,112	-800 Reduced 40.0%	1,200 $865,000
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $1.15 Million - $1.45 Million	2,000 New	2,000 $1.38 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.43 Million - $1.68 Million	-2,400 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $4.51 Million - $5.57 Million	-8,300 Reduced 77.57%	2,400 $1.52 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $3.85 Million - $4.56 Million	6,700 Added 167.5%	10,700 $6.48 Million
Q2 2020 Aug 13, 2020	SELL	$493.32 - $643.92 $345,324 - $450,744	-700 Reduced 14.89%	4,000 $2.5 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $1.58 Million - $2.32 Million	4,700 New	4,700 $2.3 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.